Related Experiment Videos
[Alternative mRNA splicing, pathology and molecular therapeutics]
Laurent Corcos1, Stéphanie Solier
1Inserm U.613, Faculté de Médecine, 22, avenue Camille Desmoulins, 29238 Brest Cedex 3, France. laurent.corcos@univ-brest.fr
Medecine Sciences : M/S
|March 5, 2005
Summary
Pre-mRNA splicing, a vital process for gene expression, exhibits variations that can lead to diseases. Therapeutic strategies are emerging to correct splicing defects and treat genetic disorders.
Area of Science:
- Molecular Biology
- Genetics
- RNA Processing
Context:
- Pre-messenger RNA (pre-mRNA) splicing is a fundamental biological process, essential for at least 95% of cellular transcripts.
- Alternative mRNA splicing introduces significant diversity, with an average of 6-8 splicing events per pre-mRNA molecule, expanding the proteomic landscape.
- Splicing defects, arising from mutations in regulatory sequences, are implicated in inherited diseases and cancer development.
Purpose:
- To investigate the role of pre-mRNA splicing variations in disease pathogenesis.
- To explore molecular approaches for correcting aberrant splicing events.
- To assess the therapeutic potential of restoring normal or surrogate transcript levels.
Summary:
- Identified mutations in splicing sequences as causative agents for transcript level variations in diseases.
- Developed and tested molecular strategies including protein overexpression, activity enhancement, splice-site modulation, and RNA trans-splicing.
- Demonstrated phenotypic improvements in animal models using these therapeutic approaches.
Impact:
- Provides a deeper understanding of the link between splicing defects and human diseases.
- Highlights the potential of RNA-based and protein-based therapies for genetic and acquired conditions.
- Offers hope for developing novel therapeutic strategies targeting pre-mRNA splicing defects.